Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Thermo Fisher Scientific (TMO) stocks

Learn how to easily invest in Thermo Fisher Scientific stocks.

Thermo Fisher Scientific is a diagnostics & research business based in the US. Thermo Fisher Scientific stocks (TMO.US) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $517.83 – a decrease of 0.8% over the previous week. Thermo Fisher Scientific employs 130,000 staff and has a trailing 12-month revenue of around $42.8 billion.

How to buy stocks in Thermo Fisher Scientific

  1. Compare stock trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – TMO – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of stocks with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Thermo Fisher Scientific stock price (NYSE:TMO)

Use our graph to track the performance of TMO stocks over time.

Thermo Fisher Scientific shares at a glance

Information last updated 2022-09-26.
Latest market close$516.61
52-week range$497.56 - $667.82
50-day moving average $567.14
200-day moving average $570.34
Wall St. target price$659.91
PE ratio 27.7163
Dividend yield $1.12 (0.23%)
Earnings per share (TTM) $18.79

Compare stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

1 - 5 of 5
Name Product Finder Rating Stock Trading Fee Account Fee Available Asset Types Offer
OFFER
CIBC Investor's Edge
Finder Rating:
★★★★★
4 / 5
$4.95–$6.95
$0 if conditions met, else $100/year
Stocks, Bonds, Options, Mutual Funds, ETFs
Young investors 18 to 24 can get free online trades and a $0 annual account fee. Conditions apply.
Interactive Brokers
Finder Rating:
★★★★★
4.1 / 5
min $1.00, max 0.5%
$0
Stocks, Bonds, Options, ETFs, Currencies, Futures
Questrade
Finder Rating:
★★★★★
4.2 / 5
$4.95 - $9.95
$0
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
Get $50 in free trades when you fund your account with a minimum of $1,000.
FREE TRADES
Wealthsimple
Finder Rating:
★★★★★
3.9 / 5
$0
$0
Stocks, ETFs
Get $25 when you open a Wealthsimple account and fund at least $150.
OFFER
Qtrade Direct Investing
Finder Rating:
★★★★★
4.1 / 5
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
Get almost $500 in commission free trades when you fund your new account with a minimum of $10,000. Conditions apply. Ends October 31, 2022.
loading

Compare up to 4 providers

Is it a good time to buy Thermo Fisher Scientific stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Thermo Fisher Scientific price performance over time

Historical closes compared with the close of $516.61 from 2022-09-29

1 week (2022-09-23) -0.80%
1 month (2022-08-26) N/A
3 months (2022-06-30) -4.91%
6 months (2022-03-26) N/A
1 year (2021-09-30) -9.58%
2 years (2020-09-30) 17.01%
3 years (2019-09-30) 77.36%
5 years (2017-09-29) 173.05%

Is Thermo Fisher Scientific under- or over-valued?

Valuing Thermo Fisher Scientific stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Thermo Fisher Scientific's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Thermo Fisher Scientific's P/E ratio

Thermo Fisher Scientific's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 28x. In other words, Thermo Fisher Scientific shares trade at around 28x recent earnings.

That's comparable to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29).

Thermo Fisher Scientific's PEG ratio

Thermo Fisher Scientific's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 3.1148. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Thermo Fisher Scientific's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Thermo Fisher Scientific's EBITDA

Thermo Fisher Scientific's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $12.8 billion.

The EBITDA is a measure of a Thermo Fisher Scientific's overall financial performance and is widely used to measure a its profitability.

Thermo Fisher Scientific financials

Revenue TTM $42.8 billion
Operating margin TTM 22.77%
Gross profit TTM $19.6 billion
Return on assets TTM 7.7%
Return on equity TTM 18.78%
Profit margin 17.37%
Book value $107.95
Market capitalisation $204 billion

TTM: trailing 12 months

Thermo Fisher Scientific's environmental, social and governance track record

Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Thermo Fisher Scientific.

When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.

Thermo Fisher Scientific's total ESG risk score

Total ESG risk: 14.69

Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Thermo Fisher Scientific's overall score of 14.69 (as at 01/01/2019) is excellent – landing it in it in the 15th percentile of companies rated in the same sector.

ESG scores are increasingly used to estimate the level of risk a company like Thermo Fisher Scientific is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).

Thermo Fisher Scientific's environmental score

Environmental score: 2.11/100

Thermo Fisher Scientific's environmental score of 2.11 puts it squarely in the 1st percentile of companies rated in the same sector. This could suggest that Thermo Fisher Scientific is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.

Thermo Fisher Scientific's social score

Social score: 6.69/100

Thermo Fisher Scientific's social score of 6.69 puts it squarely in the 1st percentile of companies rated in the same sector. This could suggest that Thermo Fisher Scientific is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.

Thermo Fisher Scientific's governance score

Governance score: 3.38/100

Thermo Fisher Scientific's governance score puts it squarely in the 1st percentile of companies rated in the same sector. That could suggest that Thermo Fisher Scientific is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.

Thermo Fisher Scientific's controversy score

Controversy score: 2/5

ESG scores also evaluate any incidences of controversy that a company has been involved in. Thermo Fisher Scientific scored a 2 out of 5 for controversy – the second-highest score possible, reflecting that Thermo Fisher Scientific has, for the most part, managed to keep its nose clean.

Thermo Fisher Scientific share dividends

5%

Dividend payout ratio: 4.63% of net profits

Recently Thermo Fisher Scientific has paid out, on average, around 4.63% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.23% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Thermo Fisher Scientific shareholders could enjoy a 0.23% return on their shares, in the form of dividend payments. In Thermo Fisher Scientific's case, that would currently equate to about $1.12 per share.

While Thermo Fisher Scientific's payout ratio might seem low, this can signify that Thermo Fisher Scientific is investing more in its future growth.

Thermo Fisher Scientific's most recent dividend payout was on 14 October 2022. The latest dividend was paid out to all shareholders who bought their shares by 14 September 2022 (the "ex-dividend date").

Have Thermo Fisher Scientific's shares ever split?

Thermo Fisher Scientific's shares were split on a 3:2 basis on 6 June 1996. So if you had owned 2 shares the day before before the split, the next day you'd have owned 3 shares. This wouldn't directly have changed the overall worth of your Thermo Fisher Scientific shares – just the quantity. However, indirectly, the new 33.3% lower share price could have impacted the market appetite for Thermo Fisher Scientific shares which in turn could have impacted Thermo Fisher Scientific's share price.

Thermo Fisher Scientific share price volatility

Over the last 12 months, Thermo Fisher Scientific's shares have ranged in value from as little as $497.5632 up to $667.8156. A popular way to gauge a stock's volatility is its "beta".

TMO.US volatility(beta: 0.86)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Thermo Fisher Scientific's is 0.8554. This would suggest that Thermo Fisher Scientific's shares are less volatile than average (for this exchange).

Thermo Fisher Scientific overview

Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs.

Frequently asked questions


Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Ask an Expert

You must be logged in to post a comment.

Go to site